Evidence map›Paper›PMID 28498481›Full record

ArticleOncology reports2017

Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.

Weifeng Xu, Bing Wu, Lengxi Fu, Junying Chen, Zeng Wang, Fei Huang, Jinrong Chen, Mei Zhang, Zhenhuan Zhang, Jingan Lin and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  4. Article
  5. Circulating BRAFThyroid : official journal of the American Thyroid Association · 2018
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Weifeng XuFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Bing WuFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Lengxi FuFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Junying ChenFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Zeng WangFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Fei HuangFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Jinrong ChenFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Mei ZhangDepartment of Radiation Oncology, University of Florida, Gainesville, FL 32610, USA.
Zhenhuan ZhangDepartment of Radiation Oncology, University of Florida, Gainesville, FL 32610, USA.
Jingan LinFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Ruilong LanFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Ruiqing ChenFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Wei ChenFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Long ChenFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Jinsheng HongFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Weijian ZhangFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Yuxiong DingFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Paul OkunieffDepartment of Radiation Oncology, University of Florida, Gainesville, FL 32610, USA.
Jianhua LinFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Lurong ZhangFirst Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
First Affiliated Hospital of Fujian Medical University · CNFujian Medical University · CNUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) represent the key step of cancer cell dissemination. The alteration of CTCs correlates with the treatment outcome and prognosis. To enrich and identify CTCs from billions of blood cells renders a very challenging task, which triggers development of several methods, including lysis of RBC plus negative or positive enrichment using antibodies, and filter membrane or spiral microfluidics to capture CTCs. To compare the advantages of different enrichment methods for CTCs, we utilized the 4T1 breast cancer cells transfected with both green fluorescent protein (GFP) and luciferase to trace CTCs in the experimental lung metastasis model. Three methods were used to detect CTCs at the same time: bioluminescence assay, smearing method, and membrane filter method. The in vivo alive mouse imaging was used to dynamically monitor the growth of lung metastases. The sensitivity and accuracy of three detection methods were compared side-by-side. Our results showed that 1) the sensitivity of bioluminescence assay was the highest, but there was no information of CTC morphology; 2) the smearing method and membrane filter method could observe the detail of CTC morphology, such as in single or in cluster, while their sensitivity was lower than bioluminescence assay; 3) A dynamic observation at a 7-day intervals, the lung metastatic cancer grew at a log speed, while CTCs were increased at a low speed. This might be due to the activated immune cells eliminating the CTCs at a speed much faster than CTCs were generated. This comparison of three CTC detection methods in mouse model suggests that bioluminescence assay could be used in quantitative study of the effect of certain agent on the suppression of CTCs, while GFP-based morphological assays could be used to study the dissemination mechanism of CTCs. The combination of both bioluminescence assay and GFP-based assay would generate more information for quantity and quality of CTCs.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorCell SeparationDisease Models, AnimalFemaleHumansLung NeoplasmsMiceNeoplastic Cells, CirculatingPrognosis

Identifiers

PMID28498481
PMCPMC5442393
OpenAlexW2610421969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.